Video Archives

Video

Early Feasibility Assessment (EFA) with Certara IQ™

Learn how Certara IQ performs early feasibility assessments (EFA) to predict biotherapeutic dosing, guide candidate…

CertaraOctober 16, 2025

Video

Certara IQ™: Predicting Recommended Phase 2 Doses with Confidence

Learn how Certara IQ predicts recommended Phase 2 doses using advanced QSP modeling workflows that…

CertaraOctober 16, 2025

Video

Certara IQ™: Model-Informed First-In-Human (FIH) Dose Selection

Discover how Certara IQ uses QSP modeling to predict safe and effective First-In-Human doses, accelerating…

CertaraOctober 16, 2025

Video

Inside Certara IQ™: Building the Future of QSP with Josh Apgar & Chris Bouton

Hear from Certara experts on how Certara IQ modernizes QSP modeling with AI, collaboration tools,…

CertaraOctober 16, 2025

Video

Microsoft Office Integration – How to Marvin

Learn how you can use Marvin with Microsoft Office Word and PowerPoint by adding JChem…

CertaraOctober 16, 2025

Video

Ask the Experts: All About Safety Documents

Get clear, practical answers to the top 5 safety reporting questions & learn how to…

CertaraOctober 7, 2025

Video

Highlights from the FDA Guidance on Dosage Optimization for Therapeutic Radiopharmaceuticals

Learn how radiopharmaceutical therapies work in oncology and how Certara supports development with modeling, simulation,…

CertaraOctober 3, 2025

Press Coverage Video

Preparing for the Operational Burden of OS Requirements in Oncology Trials

Ananth Kadambi outlines how clinical operations teams can plan for FDA’s OS requirements—enhancing patient tracking…

CertaraSeptember 26, 2025

Press Coverage Video

How RWE and Predictive Modeling Support OS-Focused Trial Designs

Discover how real-world evidence and predictive modeling strengthen OS-focused trial designs in oncology, improving efficiency…

CertaraSeptember 25, 2025

Press Coverage Video

Using Model-Informed Drug Development to Support OS Endpoints

Ananth Kadambi shares how model-informed drug development helps sponsors predict efficacy and align shorter oncology…

CertaraSeptember 24, 2025

Video

Early Feasibility Assessment (EFA) with Certara IQ™

Certara IQ™: Predicting Recommended Phase 2 Doses with Confidence

Certara IQ™: Model-Informed First-In-Human (FIH) Dose Selection

Inside Certara IQ™: Building the Future of QSP with Josh Apgar & Chris Bouton

Microsoft Office Integration – How to Marvin

Ask the Experts: All About Safety Documents

Highlights from the FDA Guidance on Dosage Optimization for Therapeutic Radiopharmaceuticals

Preparing for the Operational Burden of OS Requirements in Oncology Trials

How RWE and Predictive Modeling Support OS-Focused Trial Designs

Using Model-Informed Drug Development to Support OS Endpoints

Newsletter sign up

Quick links

Solutions

Contact